Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines forShigella,Salmonella,enterotoxigenicE. coli(ETEC) enterohemorragicE. coli(EHEC) andCampylobacter jejuni

Development and Preclinical Evaluation of a Trivalent, Formalin-Inactivated Shigella Whole-Cell Vaccine

(2014) R. W. Kaminski et al.   Clinical and Vaccine Immunology

Characterization of adaptive immune responses induced by a new genetically inactivated Salmonella Enteritidis vaccine

(2014) Chetan V. Jawale et al.   COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES

Shigella Vaccine Development: Prospective Animal Models and Current Status

(2014) Yeon-Jeong Kim et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Changing patterns and widening of antibiotic resistance in Shigella spp. over a decade (2000–2011), Andaman Islands, India

(2014) D. BHATTACHARYA et al.   EPIDEMIOLOGY AND INFECTION

Variable Efficacy of a Vaccine and Direct-Fed Microbial for Controlling Escherichia coli O157:H7 in Feces and on Hides of Feedlot Cattle

(2014) Kim Stanford et al.   Foodborne Pathogens and Disease

Immunoproteomic Analysis To Identify Shiga Toxin-Producing Escherichia coli Outer Membrane Proteins Expressed during Human Infection

(2014) David Montero et al.   INFECTION AND IMMUNITY

Development of an Aotus nancymaae Model for Shigella Vaccine Immunogenicity and Efficacy Studies

(2014) Michael Gregory et al.   INFECTION AND IMMUNITY

Comparative Genomics and Immunoinformatics Approach for the Identification of Vaccine Candidates for Enterohemorrhagic Escherichia coli O157:H7

(2014) Víctor A. García-Angulo et al.   INFECTION AND IMMUNITY

Characterization of Heat-Stable (STa) Toxoids of Enterotoxigenic Escherichia coli Fused to Double Mutant Heat-Labile Toxin Peptide in Inducing Neutralizing Anti-STa Antibodies

(2014) Xiaosai Ruan et al.   INFECTION AND IMMUNITY

Intradermal Delivery of Shigella IpaB and IpaD Type III Secretion Proteins: Kinetics of Cell Recruitment and Antigen Uptake, Mucosal and Systemic Immunity, and Protection across Serotypes

(2014) S. J. Heine et al.   JOURNAL OF IMMUNOLOGY

Passive immunity with multi-serotype heat-killed Shigellae in neonatal mice

(2014) Soumik Barman et al.   MICROBIOLOGY AND IMMUNOLOGY

Patrones de susceptibilidad antimicrobiana de cepas de Shigella sonnei aisladas durante tres períodos diferentes en la Región Metropolitana, Chile

(2014) Alicia Marcoleta et al.   Revista Chilena de Infectologia

Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines

(2014) G. Stefanetti et al.   VACCINE

Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypes

(2014) R.T. Ranallo et al.   VACCINE

Vaccines against invasive Salmonella disease

(2014) Calman A MacLennan et al.   Human Vaccines & Immunotherapeutics

Bacterial Outer Membrane Vesicles and Vaccine Applications

(2014) Reinaldo Acevedo et al.   Frontiers in Immunology

Pathobiology of Salmonella, Intestinal Microbiota, and the Host Innate Immune Response

(2014) Renato Lima Santos   Frontiers in Immunology

Evaluation of an intragastric challenge model forShigella dysenteriae1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment ofShigellavaccine formulations

(2013) Dilara Islam et al.   APMIS

Interventions for preventing diarrhea-associated hemolytic uremic syndrome: systematic review

(2013) Diana E Thomas et al.   BMC PUBLIC HEALTH

Safety and Immunogenicity of a Single Oral Dose of Recombinant Double Mutant Heat-Labile Toxin Derived from Enterotoxigenic Escherichia coli

(2013) Samer S. El-Kamary et al.   Clinical and Vaccine Immunology

Recent Advances in Understanding Enteric Pathogenic Escherichia coli

(2013) M. A. Croxen et al.   CLINICAL MICROBIOLOGY REVIEWS

Assessment of Heterogeneity of Efficacy of a Three-Dose Regimen of a Type III Secreted Protein Vaccine for Reducing STEC O157 in Feces of Feedlot Cattle

(2013) Amanda R. Vogstad et al.   Foodborne Pathogens and Disease

Current Trends in Detecting Non-O157 Shiga Toxin–Producing Escherichia coli in Food

(2013) Fei Wang et al.   Foodborne Pathogens and Disease

Characterization of a Novel Fusion Protein from IpaB and IpaD of Shigella spp. and Its Potential as a Pan-Shigella Vaccine

(2013) Francisco J. Martinez-Becerra et al.   INFECTION AND IMMUNITY

A Mouse Model of Shigellosis by Intraperitoneal Infection

(2013) Jin-Young Yang et al.   JOURNAL OF INFECTIOUS DISEASES

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

(2013) Karen L Kotloff et al.   LANCET

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala

(2013) Ronald H Behrens et al.   LANCET INFECTIOUS DISEASES

Salmonella Infections

(2013) J. C. Christenson   PEDIATRICS IN REVIEW

Sustained Protection in Mice Immunized with Fractional Doses of Salmonella Enteritidis Core and O Polysaccharide-Flagellin Glycoconjugates

(2013) Raphael Simon et al.   PLoS One

Predicting the public health benefit of vaccinating cattle against Escherichia coli O157

(2013) L. Matthews et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein

(2013) A. Lundgren et al.   VACCINE

Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant

(2013) J. Holmgren et al.   VACCINE

Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection

(2013) Victor A. Garcia-Angulo et al.   VACCINE

Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates

(2012) Joshua Tobias et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

The Oral, Live Attenuated Enterotoxigenic Escherichia coli Vaccine ACE527 Reduces the Incidence and Severity of Diarrhea in a Human Challenge Model of Diarrheal Disease

(2012) Michael J. Darsley et al.   Clinical and Vaccine Immunology

Protection by a Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Vaccine Expressing Shiga Toxin 2 B Subunit against Shiga Toxin-Producing Escherichia coli in Mice

(2012) Jun Fujii et al.   Clinical and Vaccine Immunology

Recent progress toward an enterotoxigenicEscherichia colivaccine

(2012) Ann-Mari Svennerholm et al.   Expert Review of Vaccines

An Outcomes Model to Evaluate Risks and Benefits of Escherichia coli Vaccination in Beef Cattle

(2012) H. Scott Hurd et al.   Foodborne Pathogens and Disease

Towards a non-living vaccine against Shigella flexneri: From the inactivation procedure to protection studies

(2012) A.I. Camacho et al.   METHODS

Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice

(2012) Aline Ferreira Oliveira et al.   MICROBIOLOGY AND IMMUNOLOGY

Evaluation of Salmonella enterica Serovar Typhimurium TTSS-2 Deficient fur Mutant as Safe Live-Attenuated Vaccine Candidate for Immunocompromised Mice

(2012) Vikalp Vishwakarma et al.   PLoS One

Eimeria species parasites as novel vaccine delivery vectors: Anti-Campylobacter jejuni protective immunity induced by Eimeria tenella-delivered CjaA

(2012) Julie D. Clark et al.   VACCINE

Efficacy of a vaccine and a direct-fed microbial against fecal shedding of Escherichia coli O157:H7 in a randomized pen-level field trial of commercial feedlot cattle

(2012) Charley A. Cull et al.   VACCINE

Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: A new combination of gene deletions for 2nd generation live attenuated vaccine candidates

(2012) Ryan T. Ranallo et al.   VACCINE

A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts (BGs) reduces the excretion of E. coli O157:H7 in calves

(2012) D.A. Vilte et al.   VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

Bovine innate and adaptive immune responses against Escherichia coli O157:H7 and vaccination strategies to reduce faecal shedding in ruminants

(2012) Kris Vande Walle et al.   VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

Assessing the Existing Information on the Efficacy of Bovine Vaccination againstEscherichia coliO157:H7 - A Systematic Review and Meta-analysis

(2012) N. P. Varela et al.   Zoonoses and Public Health

Glycoconjugate vaccine strategies for protection against invasiveSalmonellainfections

(2012) Raphael Simon et al.   Human Vaccines & Immunotherapeutics

Campylobacter Polysaccharide Capsules: Virulence and Vaccines

(2012) Patricia Guerry et al.   Frontiers in Cellular and Infection Microbiology

Serological Response of Shiga Toxin-Producing Escherichia coli Type III Secreted Proteins in Sera from Vaccinated Rabbits, Naturally Infected Cattle, and Humans

(2011) David J. Asper et al.   Clinical and Vaccine Immunology

Development of a new guinea-pig model of shigellosis

(2011) Soumik Barman et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Cross-Reactive Protection against Enterohemorrhagic Escherichia coli Infection by Enteropathogenic E. coli in a Mouse Model

(2011) Carla Calderon Toledo et al.   INFECTION AND IMMUNITY

Engineering and Preclinical Evaluation of Attenuated Nontyphoidal Salmonella Strains Serving as Live Oral Vaccines and as Reagent Strains

(2011) Sharon M. Tennant et al.   INFECTION AND IMMUNITY

Salmonella enterica Serovar Enteritidis Core O Polysaccharide Conjugated to H:g,m Flagellin as a Candidate Vaccine for Protection against Invasive Infection withS.Enteritidis

(2011) Raphael Simon et al.   INFECTION AND IMMUNITY

Mouse Models ofEscherichia coliO157:H7 Infection and Shiga Toxin Injection

(2011) Krystle L. Mohawk et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Distribution of Classical and Nonclassical Virulence Genes in Enterotoxigenic Escherichia coli Isolates from Chilean Children and tRNA Gene Screening for Putative Insertion Sites for Genomic Islands

(2011) Felipe Del Canto et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Escherichia coli O157:H7 Shedding in Vaccinated Beef Calves Born to Cows Vaccinated Prepartum with Escherichia coli O157:H7 SRP Vaccine

(2011) B. W. WILEMAN et al.   JOURNAL OF FOOD PROTECTION

Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins

(2011) Hong-ying Fan et al.   MOLECULAR BIOLOGY REPORTS

Salmonella enterica Serovar Typhimurium Lacking hfq Gene Confers Protective Immunity against Murine Typhoid

(2011) Uday Shankar Allam et al.   PLoS One

Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenicEscherichia coliin volunteers

(2011) Wlodzimierz Otto et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection

(2011) S. Barnoy et al.   VACCINE

Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine

(2011) Mark S. Riddle et al.   VACCINE

An attenuated Salmonella enterica serovar Typhimurium strain lacking the ZnuABC transporter induces protection in a mouse intestinal model of Salmonella infection

(2011) M. Pesciaroli et al.   VACCINE

Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice

(2011) Jiang Gu et al.   VACCINE

A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression

(2011) S.D. Isidean et al.   VACCINE

Subcutaneous and intranasal immunization with Stx2B–Tir–Stx1B–Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice

(2011) Xue-han Zhang et al.   VACCINE

A Systematic Review of Vaccinations to Reduce the Shedding of Escherichia coli O157 in the Faeces of Domestic Ruminants

(2011) K. G. Snedeker et al.   Zoonoses and Public Health

Directed Evaluation of Enterotoxigenic Escherichia coli Autotransporter Proteins as Putative Vaccine Candidates

(2011) Jessica A. Harris et al.   PLoS Neglected Tropical Diseases

Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge

(2011) Ulrike Beate Mayr et al.   Microbial Biotechnology

Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response

(2010) Kun Cai et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Salmonella enterica Serovar Typhimurium Vaccine Strains Expressing a Nontoxic Shiga-Like Toxin 2 Derivative Induce Partial Protective Immunity to the Toxin Expressed by Enterohemorrhagic Escherichia coli

(2010) R. L. G. Rojas et al.   Clinical and Vaccine Immunology

The Global Burden of NontyphoidalSalmonellaGastroenteritis

(2010) Shannon E. Majowicz et al.   CLINICAL INFECTIOUS DISEASES

Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas

(2010) Margaret Kosek et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Enterotoxigenic Escherichia coli Elicits Immune Responses to Multiple Surface Proteins

(2010) K. Roy et al.   INFECTION AND IMMUNITY

Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7

(2010) Jafar Amani et al.   VACCINE

Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers

(2010) D. Tribble et al.   VACCINE

Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children

(2010) Justen H. Passwell et al.   VACCINE

Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh

(2010) Kazi Mizanur Rahman et al.   VACCINE

Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection

(2010) Kun Cai et al.   VACCINE

A DNA Vaccine Encoding the Enterohemorragic Escherichia coli Shiga-Like Toxin 2 A2 and B Subunits Confers Protective Immunity to Shiga Toxin Challenge in the Murine Model

(2009) L. V. Bentancor et al.   Clinical and Vaccine Immunology

Efficacy of Escherichia coli O157:H7 Siderophore Receptor/Porin Proteins–Based Vaccine in Feedlot Cattle Naturally Shedding E. coli O157

(2009) J. Trent Fox et al.   Foodborne Pathogens and Disease

Use of a Siderophore Receptor and Porin Proteins-Based Vaccine to Control the Burden of Escherichia coli O157:H7 in Feedlot Cattle

(2009) Daniel U. Thomson et al.   Foodborne Pathogens and Disease

Campylobacter jejuni: A brief overview on pathogenicity-associated factors and disease-mediating mechanisms

(2009) Javid I. Dasti et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Shigella flexneri 2a Infection

(2009) A. Phalipon et al.   JOURNAL OF IMMUNOLOGY

Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: Implications for the vaccine development

(2009) Yan Cheng et al.   JOURNAL OF MICROBIOLOGY

Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice

(2009) Jiang Gu et al.   MICROBES AND INFECTION

Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector

(2009) Rogeria Keller et al.   MICROBIAL PATHOGENESIS

Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates

(2009) J. B. Robbins et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

(2009) Odile Launay et al.   VACCINE

Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity

(2009) S. Barnoy et al.   VACCINE

Immunization of cattle with a combination of purified intimin-531, EspA and Tir significantly reduces shedding of Escherichia coli O157:H7 following oral challenge

(2009) Tom N. McNeilly et al.   VACCINE

Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter antigens for control of C. jejuni in poultry

(2009) Anthony M. Buckley et al.   VACCINE

Randomized Clinical Trial Assessing the Safety and Immunogenicity of Oral Microencapsulated Enterotoxigenic Escherichia coli Surface Antigen 6 with or without Heat-Labile Enterotoxin with Mutation R192G

(2008) J. A. Lapa et al.   Clinical and Vaccine Immunology

Molecular Pathogenesis of Shigella spp.: Controlling Host Cell Signaling, Invasion, and Death by Type III Secretion

(2008) G. N. Schroeder et al.   CLINICAL MICROBIOLOGY REVIEWS

Recent Developments in Synthetic Oligosaccharide-Based Bacterial Vaccines

(2008) Vince Pozsgay   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Campylobactercolonization of the chicken induces a proinflammatory response in mucosal tissues

(2008) Christopher K. Smith et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

A Two-Dose Regimen of a Vaccine Against Type III Secreted Proteins Reduced Escherichia coli O157:H7 Colonization of the Terminal Rectum in Beef Cattle in Commercial Feedlots

(2008) David R. Smith et al.   Foodborne Pathogens and Disease

The EtpA Exoprotein of Enterotoxigenic Escherichia coli Promotes Intestinal Colonization and Is a Protective Antigen in an Experimental Model of Murine Infection

(2008) K. Roy et al.   INFECTION AND IMMUNITY

Capsule Polysaccharide Conjugate Vaccine against Diarrheal Disease Caused by Campylobacter jejuni

(2008) M. A. Monteiro et al.   INFECTION AND IMMUNITY

Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice

(2008) Shawn Babiuk et al.   MICROBIAL PATHOGENESIS

Attenuated Salmonella enterica serovar Typhimurium lacking the ZnuABC transporter confers immune-based protection against challenge infections in mice

(2008) Paolo Pasquali et al.   VACCINE

Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate

(2008) Robin McKenzie et al.   VACCINE

A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC

(2008) Robin McKenzie et al.   VACCINE

Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant

(2008) Angel Cataldi et al.   VACCINE

Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 ΔicsA Δent Δfep ΔstxA:HgR oral vaccine SC599 in healthy human adult volunteers

(2007) Christine Sadorge et al.   VACCINE